Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GB Sciences Inc GBLX

GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company. It creates patented, disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. (GBSGB). The primary focus for the development of its lead program has been in evaluating suitable... see more

Recent & Breaking News (GREY:GBLX)

Cannabis, CBD, Vape Products See Uptick in Sales in Thriving Legal Marijuana Markets

PR Newswire May 3, 2017

GB Sciences Surpasses Key Corporate Milestones, Plus Exclusive CEO Interview -- CFN Media

Marketwired May 2, 2017

The Popularity of the Legal Cannabis Industry

PR Newswire April 20, 2017

The Growth of Tax Revenues in the Legal Cannabis Market

PR Newswire April 13, 2017

GB Sciences Partners with Kush Cups to Produce Cannabis-Infused Keurig-Compatible K-Cups, Brewed Coffee and Infused Tea

PR Newswire April 10, 2017

The Continued Growth of Legal Cannabis Revenues

PR Newswire April 6, 2017

GB Sciences Submits Offer to Louisiana State University (LSU) for Providing the Cultivation, Extraction, Processing and Production of Medical Cannabis Pursuant to the Alison Neustrom Act

PR Newswire April 3, 2017

Legal Cannabis Market is Rapidly Developing

PR Newswire March 30, 2017

GB Sciences Moves Closer to Clinical Trials -- CFN Media

Marketwired March 28, 2017

Increasing Jobs in the Legal Cannabis Market

PR Newswire March 15, 2017

FinancialBuzz.com: New Data Projects Growth for the Legal Cannabis Market

PR Newswire March 10, 2017

Marijuana Stocks: How CEOs Can Navigate Market Volatility (And Survive Spicer And Sessions)

Benzinga.com  March 10, 2017

Why Cannabinoids Work Best Together -- CFN Media

Marketwired March 7, 2017

Cannabis Market Expands Globally

PR Newswire March 2, 2017

Cannabis CBD Infused Products Grow in Popularity Along With Newest Medicinal Applications and Uses

PR Newswire Europe Non Regulatory February 28, 2017

Cannabis Industry Quickly Becoming a Lucrative, Wide Open Market for Development of Innovative Products and Services

PR Newswire Europe Non Regulatory February 10, 2017

GB Sciences Embraces Cannabinoid Complexities, Plus New Interview -- CFN Media

Marketwired February 9, 2017

Cannabis Asset Expansions and Acquisitions Quickly Becoming Catalyst For Exploding Marijuana Industry Growth

PR Newswire Europe Non Regulatory February 8, 2017

GB Sciences Files Patent Application for the Treatment of Chronic Arthritis, Crohn's Disease, Inflammatory Bowel Disease, and Asthma; Proprietary Cannabinoid-Containing Complex Mixtures for the Treatment of Inflammatory Disorders

PR Newswire February 6, 2017

GB Sciences Resets: Exclusive Executive Interview with CFN Media

Marketwired January 23, 2017